The Will Rogers Phenomenon: Stage Migration and New Diagnostic Techniques as a Source of Misleading Statistics for Survival in Cancer

New England Journal of Medicine

Volumn 312, Issue 25, 1985, Pages 1604-1608

  Feinstein, Alvan R ^a,b   Sosin, Daniel M ^a,b   Wells, Carolyn K ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSIS; HUMAN; LUNG CARCINOMA; PRIORITY JOURNAL; RESPIRATORY SYSTEM; STATISTICS;

EID: 0021868905     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198506203122504     Document Type: Article

References (23)

1. Feinstein AR. Symptoms as an index of biological behaviour and prognosis in human cancer. Nature 1966; 209: 241–5.
2. Feinstein. A new staging system for cancer and a reappraisal of “early” treatment and “cure” by radical surgery. N Engl J Med 1968; 279: 747–53.
3. Feinstein AR, Wells CK. Lung cancer staging: a critical evaluation. Clin Chest Med 1982; 3: 291–305.
4. Feinstein AR, Schimpff CR, Hull EW. A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging. Arch Intern Med 1975; 135: 1441–53.
5. Feinstein. A reappraisal of staging and therapy for patients with cancer of the rectum. II. Patterns of presentation and outcome of treatment. Arch Intern Med 1975; 135: 1454–62.
6. Feinstein AR, Schimpff CR, Andrews JF Jr, Wells CK. Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. J Chronic Dis 1977; 30: 277–305.
7. Feinstein AR. A clinical method for estimating the rate of growth of a cancer. Yale J Biol Med 1969; 41: 422–33.
8. Charlson ME, Feinstein AR. A new clinical index of growth rate in the staging of breast cancer. Am J Med 1980; 69: 527–36.
9. Wells CK, Stoller JK, Feinstein AR, Horwitz RI. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984; 144: 2004–9.
10. Boyd NF, Feinstein AR. Symptoms as an index of growth rates and prognosis in Hodgkin's disease. Clin Invest Med 1978; 1: 25–31.
11. Boyd NF, Clemens JD, Feinstein AR. Pretherapeutic morbidity in the prognostic staging of acute leukemia. Arch Intern Med 1979; 139: 324–8.
12. Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations. Arch Intern Med 1969; 123: 323–44.
13. Feinstein. The epidemiology of cancer therapy. III. The management of imperfect data. Arch Intern Med 1969; 123: 448–61.
14. Feinstein. The epidemiology of cancer therapy. IV. The extraction of data from medical records. Arch Intern Med 1969; 123: 571–90.
15. Feinstein AR. The problems of quantifying prognosis in lung cancer. In: Lane DJ, ed. Respiratory disease. London: William Heinemann, 1976:444–64.
16. Manual for staging cancer 1978. Chicago: American Joint Committee for Cancer Staging and End Results Reporting, 1978.
17. Hutchison GB, Shapiro S. Lead time gained by diagnostic screening for breast cancer. JNCI 1968; 41: 665–73.
18. Feinleib M, Zelen M. Some pitfalls in the evaluation of screening programs. Arch Environ Health 1969; 19: 412–5.
19. Ihde DC, Hansen HH. Staging procedures and prognostic factors in small cell carcinoma of the lung. In: Greco FA, Oldham RK, Bunn PA Jr, eds. Small cell lung cancer. New York: Grune & Stratton, 1981:261–83.
20. Simon MA. Causes of increased survival of patients with osteosarcoma: current controversies. J Bone Joint Surg [Am] 1984; 66: 306–10.
21. Feinstein AR. On classifying cancers while treating patients. Arch Intern Med (in press).
22. Idem. Clinical epidemiology: the architecture of clinical research. Philadelphia: WB Saunders, 1985.
23. Idem. An additional basic science for clinical medicine. IV. The development of clinimetrics. Ann Intern Med 1983; 99: 843–8.